Sponsored session - Co-designing and implementing the Global Platform for Access to Childhood Cancer Medicines

Sponsored session - Co-designing and implementing the Global Platform for Access to Childhood Cancer Medicines

Plenary E (level +3)
Sponsored session

Information

Session organised by St. Jude Children's Research Hospital

Chaired by Carlos Rodriguez-Galindo, St. Jude Children's Research Hospital (United States)

Presentations:

1. Pannel discussion - Tsetsegsaikhan Batmunkh, National Cancer Council (Mongolia)

2. Pannel discussion - Justin Mulindwa, Cancer Diseases Hospital (Zambia)

3. Pannel discussion - Andre Ilbawi, World Health Organization (WHO) (Switzerland)

4. Pannel discussion - Dorcas Noertoft, UNICEF (Denmark)

5. Pannel discussion - Mauricio Maza,, Pan American Health Organization/World Health Organization (United States)

6. Pannel discussion - Silvia Lissette Mármol Egas, Baca Ortiz Pediatric Hospital (Ecuador)

Theme
3. Healthcare systems and policies
Objectives
The Global Platform for Access to Childhood Cancer Medicines is a collaborative initiative created by St. Jude Children’s Research Hospital and World Health Organization to provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries for the treatment of childhood cancer. In partnership with UNICEF, PAHO Strategic Fund, and many other contributors across the world, the development and implementation of the Global Platform has emphasized the co-design process with participating countries. This session will focus on our collective experience.
St. Jude Children's Research HospitalSt. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. St. Jude Global brings together individuals and institutions dedicated to improving quality of care and increasing survival rates worldwide for children with cancer and other catastrophic diseases. Through this initiative, St. Jude has made a commitment to fulfilling the founding vision of the institution: that no child should die in the dawn of life. St. Jude Global is organized into seven regional programs and a growing number of transversal programs, integrating research, innovation, and advanced education with program and capacity building. The St. Jude Global Alliance brings together more than 200 member institutions and foundations that are committed to addressing disparities in access to diagnosis and care around the world. St. Jude is the only WHO Collaborating Centre for Childhood Cancer and has partnered with WHO to create the Global Initiative for Childhood Cancer and is developing the Global Platform for Access to Childhood Cancer Medicines to address the inconsistent availability of quality essential cancer medicines.

Log in

See all the content and easy-to-use features by logging in or registering!